Search This Blog

Monday, February 22, 2021

Prelim Data Shows Single Pfizer, AstraZeneca Shot Significantly Cuts Hospitalization Risk

 Preliminary data from Scotland showed a single shot of Covid-19 vaccines developed by Pfizer Inc. and AstraZeneca PLC substantially reduced the risk of hospitalization with the disease.

A study published online reported that the risk of hospitalization with Covid-19 among those vaccinated with the Pfizer shot was 85% lower than unvaccinated individuals between 28 and 34 days after injection. There were 94% fewer hospitalizations among those vaccinated with the AstraZeneca shot than among those unvaccinated.

The findings, which haven't yet been peer-reviewed, add to a growing body of international evidence that vaccines have a significant effect on the severity of disease.

The Scottish study examined health records associated with 5.4 million people, making it one of the largest such studies to date.

https://www.marketscreener.com/quote/stock/PFIZER-INC-23365019/news/Pfizer-Preliminary-Data-Shows-Single-Pfizer-AstraZeneca-Shot-Significantly-Lowers-Risk-of-Hospita-32498603/

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.